Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants.

Y, Weisblum; F, Schmidt; F, Zhang; J, DaSilva; D, Poston; JC, Lorenzi; F, Muecksch; M, Rutkowska; HH, Hoffmann; E, Michailidis; C, Gaebler; M, Agudelo; A, Cho; Z, Wang; A, Gazumyan; M, Cipolla; L, Luchsinger; CD, Hillyer; M, Caskey; DF, Robbiani; CM, Rice; MC, Nussenzweig; T, Hatziioannou; PD, Bieniasz

doi:10.7554/elife.61312

Public

Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants.

Shared by NobleBlocks on Oct 28, 2020 • 12:00 AM UTC

Authors:

Weisblum Y

Schmidt F

Zhang F

Abstract

Neutralizing antibodies elicited by prior infection or vaccination are likely to be key for future protection of individuals and populations against SARS-CoV-2. Moreover, passively administered antibodies are among the most promising therapeutic and prophylactic anti-SARS-CoV-2 agents. However, the ...

Subject

Virus

Microbiology

Antibody

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!